THC - Here's Why You Should Retain Ensign Group Stock Now | Benzinga
The Ensign Group, Inc. (NASDAQ: ENSG) is benefiting from improved service revenues, a series of acquisitions and a strong financial position. An optimistic 2024 business outlook also reinforces investors' confidence in the stock.
Zacks Rank & Price Performance
Ensign Group carries a Zacks Rank #3 (Hold) at present.
The stock has gained 32.2% in the past year compared with the industry's 36.1% growth. The Medical sector and the S&P 500 composite index have increased 6% and 23.7%, respectively, in the same time frame.
Image Source: Zacks Investment Research
Robust Growth Prospects
The Zacks Consensus Estimate for Ensign Group's 2024 earnings is pegged at $4.95 per share, indicating an improvement of 12.6% from the year-earlier reading, while the same for revenues stands at $4.1 billion, implying an 11% increase from the prior-year actual.
The consensus mark for 2025 earnings is pegged at $5.46 per share, indicating 10.2% growth from the 2024 estimate. The same for revenues is $4.5 billion, which indicates a rise of 9.4% from the 2024 estimate.
Decent Surprise History
ENSG's earnings outpaced estimates in two of the trailing four quarters and matched the mark twice, the average surprise being 0.95%.
Solid Return on Equity
Ensign Group's efficiency in utilizing shareholders' funds can be substantiated by its return on equity of 19.1% as of Mar 31, 2024, against the industry's negative return of 13.8%.
A Favorable 2024 Outlook
ENSG anticipates revenues within the range of $4.13-$4.17 billion in 2024, the midpoint of which indicates 11.3% growth from the 2023 reported figure.
Adjusted ...